Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-054948
Filing Date
2025-06-17
Accepted
2025-06-17 07:02:14
Documents
2
Period of Report
2025-06-17

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea024591302-6k_purple.htm 6-K 14319
2 PRESS RELEASE ISSUED BY PURPLE BIOTECH LTD. ON JUNE 17, 2025 ea024591302ex99-1_purple.htm EX-99.1 14072
  Complete submission text file 0001213900-25-054948.txt   29661
Mailing Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104
Business Address 4 OPPENHEIMER STREET SCIENCE PARK REHOVOT L3 7670104 97239333121
PURPLE BIOTECH LTD. (Filer) CIK: 0001614744 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-37643 | Film No.: 251051803
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)